Catarina Silva-Macedo
Porto, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Chronotype-based radiotherapy in localised prostate cancer: protocol for a prospective cohort integrating MCTQ and salivary DLMO.
Journal: Clinical and translational radiation oncology
Published: April 22, 2026
Clinical Translation of Patient-Derived Organoids: Perspectives for Personalized Therapy in Cancer.
Journal: International journal of cancer
Published: February 18, 2026
Exploring SLC1A5 (ASCT2), SLC7A5, and SLC3A2 (LAT1) Genetic Variants in Colorectal Cancer: Implications for Prognosis and Personalized Care.
Journal: Anticancer research
Published: December 23, 2025
Bridging phenotype and function in bladder cancer using immuno-competent organoids and ex vivo drug screening.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 14, 2025
Therapeutic vulnerabilities exposed by the 9p21 loss identified through multiparametric drug screening inform rational combination strategies.
Journal: NPJ precision oncology
Published: September 01, 2025
Novel rectal cancer spheroid models reveal metabolic and transcriptional adaptations driving radiotherapy response.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 30, 2025
Impact of radiotherapy timing on survival and radiotoxicity outcomes in localized prostate cancer: a retrospective cohort study.
Journal: La Radiologia medica
Published: June 20, 2025
Translating G9a epigenetics' role: From cell machinery to cancer therapy.
Journal: Gene
Published: June 04, 2025
Genetic markers of thrombophilia as predictors of outcome in colorectal cancer.
Journal: Journal of thrombosis and thrombolysis
Published: April 28, 2025
Decoding MUC1 and AR axis in a radiation-induced neuroendocrine prostate cancer cell-subpopulation unveils novel therapeutic targets.
Journal: Cell death discovery
Published: January 15, 2025
Correction: Redefining prostate cancer risk stratification: a pioneering strategy to estimate outcome based on Ki67 immunoscoring.
Journal: Biomarker research
Published: October 12, 2024
Last Updated: 09/26/2026